These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 4544515)

  • 1. The immunopathogenesis of multiple sclerosis.
    Bornstein MB
    Mt Sinai J Med; 1974; 41(1):46-55. PubMed ID: 4544515
    [No Abstract]   [Full Text] [Related]  

  • 2. Biology of disease. Analysis of autoimmune demyelination: its impact upon multiple sclerosis.
    Raine CS
    Lab Invest; 1984 Jun; 50(6):608-35. PubMed ID: 6202955
    [No Abstract]   [Full Text] [Related]  

  • 3. Properties and significance of the demyelinating antibody in multiple sclerosis.
    Lumsden CE
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:247-75. PubMed ID: 5373029
    [No Abstract]   [Full Text] [Related]  

  • 4. Viral and immune mechanisms of demyelination.
    Salazar AM; Gibbs CJ; Gajdusek DC
    Bull Soc Belge Ophtalmol; 1983 Nov; 208 Pt 1():113-20. PubMed ID: 6202351
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental allergic encephalomyelitis: a light and electron microscope study of remyelination and "sclerosis" in vitro.
    Raine CS; Bornstein MB
    J Neuropathol Exp Neurol; 1970 Oct; 29(4):552-74. PubMed ID: 5471921
    [No Abstract]   [Full Text] [Related]  

  • 6. [What do morphological investigations add to our knowledge of multiple sclerosis (MS)?].
    Ulrich J
    Schweiz Rundsch Med Prax; 1974 Nov; 63(45):1338-42. PubMed ID: 4438252
    [No Abstract]   [Full Text] [Related]  

  • 7. [The nature of the demyelinating process in clinical and experimental neurology].
    Markov DA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969; 69(7):967-75. PubMed ID: 5368925
    [No Abstract]   [Full Text] [Related]  

  • 8. Neuropathobiology of multiple sclerosis.
    Peterson JW; Trapp BD
    Neurol Clin; 2005 Feb; 23(1):107-29, vi-vii. PubMed ID: 15661090
    [No Abstract]   [Full Text] [Related]  

  • 9. The pathology of multiple sclerosis.
    Lucchinetti CF; Parisi J; Bruck W
    Neurol Clin; 2005 Feb; 23(1):77-105, vi. PubMed ID: 15661089
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparative neuropathology of chronic experimental allergic encephalomyelitis and multiple sclerosis.
    Lassmann H
    Schriftenr Neurol; 1983; 25():1-135. PubMed ID: 6605578
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pathogenesis of multiple sclerosis and other neural autoimmune diseases].
    Lassmann H
    Verh Dtsch Ges Pathol; 1996; 80():109-15. PubMed ID: 9064993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pathology of multiple sclerosis.
    Seitelberger F
    Ann Clin Res; 1973 Oct; 5(5):337-44. PubMed ID: 4792208
    [No Abstract]   [Full Text] [Related]  

  • 13. Symposium on etiology, diagnosis and treatment of multiple sclerosis. Recent concepts of etiology: implications for treatment.
    Silberberg DH
    Mod Treat; 1970 Sep; 7(5):879-89. PubMed ID: 4933353
    [No Abstract]   [Full Text] [Related]  

  • 14. [An outline of pathomorphology of demyelinating diseases in the aspect of the exogenous antigen theory].
    Iwanowski L
    Pol Tyg Lek; 1974 Sep; 29(38):1641-2. PubMed ID: 4605502
    [No Abstract]   [Full Text] [Related]  

  • 15. Etiologic correlations between idiopathic polyneuritis and multiple sclerosis: therapeutic implications.
    Arnason BG; Mantos JJ
    Mod Treat; 1970 Sep; 7(5):903-17. PubMed ID: 4326376
    [No Abstract]   [Full Text] [Related]  

  • 16. Multiple sclerosis and the spectrum of CNS inflammatory demyelinating diseases.
    Lucchinetti CF
    Semin Neurol; 2008 Feb; 28(1):3-6. PubMed ID: 18256982
    [No Abstract]   [Full Text] [Related]  

  • 17. The pathology of multiple sclerosis and its evolution.
    Lassmann H
    Philos Trans R Soc Lond B Biol Sci; 1999 Oct; 354(1390):1635-40. PubMed ID: 10603616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of demyelination and tissue damage in multiple sclerosis.
    Lassmann H
    Acta Neurol Belg; 1999 Mar; 99(1):6-10. PubMed ID: 10218087
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Demyelinating diseases--antibody and its analysis].
    Yonezawa T
    Nihon Rinsho; 1970 Sep; 28(9):2213-22. PubMed ID: 4918162
    [No Abstract]   [Full Text] [Related]  

  • 20. Oligodendrocytes: the putative target cells of multiple sclerosis.
    Abramsky O
    Isr J Med Sci; 1982 Jan; 18(1):149-58. PubMed ID: 7040297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.